Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19

The main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variabi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: L. N. Bubnova, I. E. Pavlova, A. S. Berkos, M. A. Terentyeva, T. V. Glazanova, L. V. Erokhina, E. V. Belyaeva, A. V. Chechetkin, N. S. Bashketova, I. G. Chkhindzheria, M. А. Kozhemyakina, D. V. Azarov, R. N. Kuznetsova, Areg A. Totolyan
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
hla
Acceso en línea:https://doaj.org/article/1fe9db40b6c64aadbbf23525c321c41b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1fe9db40b6c64aadbbf23525c321c41b
record_format dspace
spelling oai:doaj.org-article:1fe9db40b6c64aadbbf23525c321c41b2021-11-18T08:03:51ZDistribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-191563-06252313-741X10.15789/1563-0625-DPO-2334https://doaj.org/article/1fe9db40b6c64aadbbf23525c321c41b2021-06-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2334https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XThe main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variability of HLA alleles in human populations have attracted close attention and became the basis for numerous studies aimed at evaluating the role of HLA genotypes for individual features of immune response to COVID-19, the new infection caused by SARS-CoV-2 β-coronavirus. Many studies have focused on search of specific alleles associated with both susceptibility and resistance to this disease. Separate HLA patterns were reported already. These patterns may be either universal to several populations, or rather peculiar, since distribution of HLA genes is different for various populations, depending on the living conditions, including specific protection from environmental pathogens. Therefore, it is evident that individual effects of HLA genotype upon occurrence and course of SARS-CoV-2 infection should be performed in comparison with the HLA distribution among the residents of appropriate region. The objective of this study was to compare the distribution of HLA-A*, B*, DRB1* allele groups, and to analyze the frequencies of HLA-AB-DRB1 haplotypes in subjects with COVID-19 (n = 138), compared with the control group presented by residents of the North-Western Russia (n = 1456). The most significant differences between COVID-19 patients compared with a group from control population were revealed for the groups of HLA-A* alleles: the frequencies of HLA-A*02 and HLA-A*26 were significantly reduced (39.86% versus 51.72%, χ2 = 7,58, and 4.35% versus 9.07%, χ2 = 4.17, respectively). At the same time, the frequency of HLA-A*29 was increased more than 2-fold (5.80% versus 2.47%, χ2 = 4.03). This finding suggests that the allele groups A*02 and A*26 are associated with reduced likelihood of the disease, while A*29, is an apparent factor predisposing for susceptibility to the disease. It was found that occurrence of definite HLA haplotypes, including the A*02 allele group, is less common in persons who have undergone COVID-19, and are ranged at the 4th, 7th and 10th positions in frequency, while in the population control group such HLA haplotypes took the 3rd, 4th, 7th and 8th places. Further evaluation of the HLA gene polymorphism will allow to understand the predetermined immunogenetic basis for susceptibility, as well as clinical severity of COVID-19.L. N. BubnovaI. E. PavlovaA. S. BerkosM. A. TerentyevaT. V. GlazanovaL. V. ErokhinaE. V. BelyaevaA. V. ChechetkinN. S. BashketovaI. G. ChkhindzheriaM. А. KozhemyakinaD. V. AzarovR. N. KuznetsovaAreg A. TotolyanSPb RAACIarticlemajor hystocompatibility complexhlaalleleshaplotypesImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 3, Pp 523-532 (2021)
institution DOAJ
collection DOAJ
language RU
topic major hystocompatibility complex
hla
alleles
haplotypes
Immunologic diseases. Allergy
RC581-607
spellingShingle major hystocompatibility complex
hla
alleles
haplotypes
Immunologic diseases. Allergy
RC581-607
L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
description The main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variability of HLA alleles in human populations have attracted close attention and became the basis for numerous studies aimed at evaluating the role of HLA genotypes for individual features of immune response to COVID-19, the new infection caused by SARS-CoV-2 β-coronavirus. Many studies have focused on search of specific alleles associated with both susceptibility and resistance to this disease. Separate HLA patterns were reported already. These patterns may be either universal to several populations, or rather peculiar, since distribution of HLA genes is different for various populations, depending on the living conditions, including specific protection from environmental pathogens. Therefore, it is evident that individual effects of HLA genotype upon occurrence and course of SARS-CoV-2 infection should be performed in comparison with the HLA distribution among the residents of appropriate region. The objective of this study was to compare the distribution of HLA-A*, B*, DRB1* allele groups, and to analyze the frequencies of HLA-AB-DRB1 haplotypes in subjects with COVID-19 (n = 138), compared with the control group presented by residents of the North-Western Russia (n = 1456). The most significant differences between COVID-19 patients compared with a group from control population were revealed for the groups of HLA-A* alleles: the frequencies of HLA-A*02 and HLA-A*26 were significantly reduced (39.86% versus 51.72%, χ2 = 7,58, and 4.35% versus 9.07%, χ2 = 4.17, respectively). At the same time, the frequency of HLA-A*29 was increased more than 2-fold (5.80% versus 2.47%, χ2 = 4.03). This finding suggests that the allele groups A*02 and A*26 are associated with reduced likelihood of the disease, while A*29, is an apparent factor predisposing for susceptibility to the disease. It was found that occurrence of definite HLA haplotypes, including the A*02 allele group, is less common in persons who have undergone COVID-19, and are ranged at the 4th, 7th and 10th positions in frequency, while in the population control group such HLA haplotypes took the 3rd, 4th, 7th and 8th places. Further evaluation of the HLA gene polymorphism will allow to understand the predetermined immunogenetic basis for susceptibility, as well as clinical severity of COVID-19.
format article
author L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
author_facet L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
author_sort L. N. Bubnova
title Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_short Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_full Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_fullStr Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_full_unstemmed Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_sort distribution patterns of hla-a<sup>*</sup>, b<sup>*</sup>, drb1<sup>*</sup> allele groups among persons who underwent covid-19
publisher SPb RAACI
publishDate 2021
url https://doaj.org/article/1fe9db40b6c64aadbbf23525c321c41b
work_keys_str_mv AT lnbubnova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT iepavlova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT asberkos distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT materentyeva distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT tvglazanova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT lverokhina distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT evbelyaeva distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT avchechetkin distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT nsbashketova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT igchkhindzheria distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT makozhemyakina distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT dvazarov distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT rnkuznetsova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT aregatotolyan distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
_version_ 1718422275311534080